Treatment response assessment in IDH-mutant glioma patients by non-invasive 3D functional Spectroscopic Mapping of 2-Hydroxyglutarate

PURPOSE: Measurements of objective response rates are critical to evaluate new glioma therapies. The hallmark metabolic alteration in gliomas with mutant isocitrate dehydrogenase (IDH) is the overproduction of oncometabolite 2-hydroxyglutarate (2HG), which plays a key role in malignant transformatio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Andronesi, Ovidiu C., Loebel, Franziska, Bogner, Wolfgang, Marjaǹska, Małgorzata, Vander Heiden, Matthew G., Iafrate, A. John, Dietrich, Jorg, Batchelor, Tracy T., Gerstner, Elizabeth R., Kaelin, William G., Chi, Andrew S., Rosen, Bruce R., Cahill, Daniel P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818725/
https://ncbi.nlm.nih.gov/pubmed/26534967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0656
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky